Economic burden of individual suffering from atrial fibrillation-related stroke in China

Value in Health Regional Issues

Volumn 2, Issue 1, 2013, Pages 135-140

  Hu, Shanlian ^a,b   Zhan, Lin ^c   Liu, Bao ^b   Gao, Yue ^b,d   Li, Yan ^e   Tong, Rongsheng ^f   Wu, Lin ^g   Yu, Bo ^h   Gao, Shen ⁱ  

^a Shanghai Center of Biomedicine Development   (China)

^b FUDAN UNIVERSITY   (China)

^c Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd   (China)

^d Shanghai Guided Medical Scientific Co Ltd   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^g GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^h CHINA MEDICAL UNIVERSITY   (China)

ⁱ SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Cost of illness; Ischemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOLYTIC AGENT; OZAGREL; WARFARIN;

ABSENTEEISM; AGED; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; COST UTILITY ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEART ATRIUM FIBRILLATION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT SELECTION; PNEUMONIA; PRIORITY JOURNAL; RANKIN SCALE; RETIREMENT; RETROSPECTIVE STUDY;

EID: 84877103921     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2013.02.008     Document Type: Article

References (17)

1. Wenhua W, Dong Z, Guixian W, et al. Trend analyses in the incidence of acute intracerebral hemorrhage events and acute cerebral infarction events in urban areas in Beijing. Chin J Epidemiol 2002;23:352-5.
2. Wenhua W., Dong Z., Guixian W., et al. The trend of incidence rate of acute stroke event in urban areas, Beijing from 1984 to 1999. Chin J Epidemiol 2001, 22:35-38.
3. Yi Long Wang, Di Wu, Xiaoling Liao, et al. Burden of stroke in China. Int J Stroke 2007, 2:211-213.
4. Ministry of Health of the People's Republic of China. Available from: , 2005. http://www.moh.gov.cn/mohbgt/s8274/list.shtml.
5. Brüggenjürgen B., Rossnagel S.R.K., Andersson F.L., et al. The impact of atrial fibrillation on the cost of stroke: the Berlin acute stroke Study. Value Health 2007, 10:137-143.
6. Kirschstein R. Disease-specific estimates of direct and indirect costs of illness and NIH support. Fiscal year 2000 update. 2000 . Available from: . [Accessed December 8, 2005]. http://ospp.od.nih.gov/ecostudies/COIreportweb.htm.
7. Zhu T.Y., Tam L.S., Li E.K. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study. Rheumatology 2011, 50:1293-1301.
8. Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998, 13:1-7.
9. Hodgson T.A., Meiners M.R. Cost of illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q 1982, 60:429-462.
10. Rice DP, Kelman S, Miller LS, et al. The economic costs of alcohol and drug abuse and mental illness, 1985[M]. US Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1990.
11. Rice D.P. Estimating the cost of illness. Am J Pub Health 1967, 57:424-440.
12. Shanlian Hu, Xiangguang Gibg, the burden of china's ischemic stroke, China Health Economics, 2003;22:18-20.
13. Van Walraven C., Hart R.G., Connolly S., et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation. The Atrial Fibrillation Investigators. Eur Heart J 2006, 27:3018-3026.
14. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
15. Zhou ZQ, Hu DY, Chen J, et al. An epidemiological survey of atrial fibrillation in China [J]. Zhonghua nei ke za zhi [Chinese journal of internal medicine], 2004;43:491.
16. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
17. Claesson L., Gosman-Hedstrom G., Johannesson M., et al. Resource utilization and costs of stroke unit care integrated in a care continuum: a 1-year controlled, prospective, randomized study in elderly patients: the Goteborg 70+ Stroke Study. Stroke 2000, 31:2569-2577.